APOTHEEK TAMPERE
Board
1 director, 1 in day-to-day management, no change since 2024Director (not named in the articles)
appointed by deed of 27-03-2024
earlier statutory director, until 27-03-2024
listed in the 2025 annual accounts, filed on 16-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder.”deed of 27-03-2024
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Day-to-day manager
LeadershipBoardEarlier
Mandates as a list
-
- Statutory manager, appointed by deed of 09-06-2009, until 27-03-2024
- Director (not named in the articles), appointed by deed of 27-03-2024, still in office
-
- Day-to-day manager, appointed by deed of 14-08-2024, still in office
With Starter you also see 1 former office holder in the mandate history.
See the plans →
Control
share not stated
This company
APOTHEEK TAMPERE
Equity €220,162
Profit €49,653 in 2025
Capital
- Contribution
- €18,550
- Shares
- 100
- Contribution per share
- €186
- Equity per share
- €2,202 in 2025
- Source
- deed of 15-01-2024
Articles of association
deed of 27-03-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 30 April at 10:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- Een of meerdere vereffenaars aanduiden,bevoegdheden omlijnen,vergoeding bepalen, indien geen andere vereffenaar benoemd
Capital transactions
Capital over time
- 27-03-2024 Capital stated in the deed · 100 shares
- 15-01-2024 Converted to unavailable equity · €18,550